Treatment For Maple Syrup Urine Disease Among 10 New EU Filings

 
• By Neena Brizmohun

REC 0545, for MSUD, and aztreonam-avibactam, for serious Gram-negative bacterial infections, are among the latest drugs that the European Medicines Agency has started reviewing for potential pan-EU marketing approval.

The EU regulator has started reviewing marketing applications for a new batch of medicines • Source: Shutterstock

More from Review Pathways

More from Pathways & Standards